1.Expression and clinical implication of TGF-? and TGF-?1 in pancreatic carcinoma
Qiang WANG ; Bin ZHANG ; Weiyu HU ; Shun ZHANG
Chinese Journal of Current Advances in General Surgery 2004;0(05):-
Objective:To explore the expression of TGF-?,TGF-?1 in the tissues of pancreatic adenocarcinoma and normal pancreas,and study the changes and the relationships with the clinicopathological parameters of pancreatic adenocarcinomas.Methods:The expressions of the TGF-?,TGF-?1 were assayed in formalin-fixed paraffin embedded samples of 41 patients with pancreatic adenocarcinoma and 12 normal pancreatic tissues by means of SABC immunohistochemistry.The relationships between the expression and clinical parameters were analysied,such as ages,gender,tumor size,location,degree of differentiation and stage(UICC).Results:The positive rate of TGF-?,TGF-?1 were73.2%,63.4% respectively in pancreatic adenoeareinoma and were16.7 %,25% respectively in normal pancreatic tissues.Significant differences were found between the two groups(P
2.Prognosis of primary liver cancer with different pathological types after hepatectomy: a report of 567 cases
Liqun WU ; Jingyu CAO ; Zusen WANG ; Fabo QIU ; Weidong GUO ; Bin ZHANG ; Shun ZHANG
Chinese Journal of Digestive Surgery 2012;(6):561-565
Objective To investigate the prognosis of patients with primary liver cancer in different pathological types after hepatectomy,and to analyze the effects of clinicopathological factors on the survival.Methods The clinical data of 567 patients with primary liver cancer who received hepatectomy at the Affiliated Hospital of Qingdao University from January 1997 to December 2008 were retrospectively analyzed.All patients were divided into hepatocellular carcinoma (HCC) group,cholangiocarcinoma (CC) group and combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) group.The survival and risk factors of the patients were analyzed.All data were analyzed by using the chi-square test,t test,analysis of variance.The survival curve was drawn by the Kaplan-Meier method and the survival of the 3 groups was compared by the Log-rank test.The risk factors were analyzed by the one-way analysis of variance and COX regression model.Results The results of pathological examination confirmed that 92.9% (527/567) patients were with HCC,4.6% (26/576) with CC and 2.5% (14/567)with cHCC-CC.The median cumulative survival time of patients with HCC was 48 months,which was significantly longer than 19 months of patients with CC and 14 months of patients with cHCC-CC (Log-rank value =4.354,8.847,P < 0.05).The median tumor-free survival time of patients with HCC was 26 months,which was significantly longer than 9 months of patients with CC and 9 months of patients with cHCC-CC (Log-rank value =6.479,7.708,P < 0.05).The tumor recurrence rate within 1 year of patients with HCC was 28.8% (152/527),which was significantly lower than 57.7% (15/26) of patients with CC or 9/14 of patients with cHCC-CC (F =17.046,P < 0.05).No vascular thrombosis was detected in patients with CC,but the regional lymph node metastasis rate was 19.2% (5/26),which was significantly higher than 2.8% (15/527) of patients with HCC (x2 =19.082,P < 0.05).Level of alpha-fetoprotein,TNM staging,tumor diameter,multiple foci,liver capsule invasion,satellite foci and lymph node metastasis were risk factors for the survivals of patients with primary liver cancer after hepateetomy (x2 =8.648,118.786,59.548,7.639,13.200,43.842,15.540,P < 0.05).Vascular tumor thrombosis and Child-Pugh classification were the risk factors for the survivals of patients with HCC or cHCC-CC (x2 =70.446,6.230,P < 0.05).TNM staging,tumor diameter,satellite foci and vascular tumor thrombusis were the independent risk factors for the survivals of patients with primary liver cancer (RR =1.420,1.050,1.513,1.899,P < 0.05) ; TNM staging,tumor diameter and vascular tumor thrombosis were the independent risk factors for the survivals of patients with HCC (RR =1.432,1.888,1.052,P < 0.05).TNM staging and tumor diameter were the independent risk factors for the survivals patients with CC (RR =1.473,1.503,P < 0.05).Conclusion Although CC and cHCC-CC take small proportion in the primary liver cancer,the tumor recurrence rate is higher and the survival rate is lower when compared with patients with HCC.
3.Research progress of emodin anti-gallbladder carcinoma.
Rui-Tao WANG ; Han YIN ; Shun-Bin DONG ; Wei YUAN ; Yan-Ping LIU ; Chang LIU
China Journal of Chinese Materia Medica 2014;39(11):1976-1978
Emodin is an effective active ingredient extracted from Chinese herbal medicine, which has the function of antimicrobial, anti-inflammatory, antioxidant and scavenging oxygen free radicals, inhibiting platelet aggregation, improving microcirculation, protecting various organs and tissues as well as a wide range of anti-tumor effect. Primary biliary gallbladder is a common malignant tumor resection rate and lack of effective adjuvant treatment. It has been confirmed that emodin has broad spectrum antitumor effect, whereas, whether it has curative effect in the treatment of gallbladder carcinoma there is no reliable clinical trials confirmed that its resistance to gallbladder carcinoma function needs further experimental research. In this review, we report the research progress of emodin anti-gallbladder carcinoma.
Animals
;
Antineoplastic Agents
;
therapeutic use
;
Drugs, Chinese Herbal
;
therapeutic use
;
Emodin
;
therapeutic use
;
Gallbladder
;
drug effects
;
Gallbladder Neoplasms
;
drug therapy
;
Humans
4.A comparative study between the extraperitoneal and transabdominal approach in resection of primary retroperitoneal tumors
Fabo QIU ; Liqun WU ; Shun ZHANG ; Haofu WANG ; Bingyuan ZHANG ; Bin ZHANG ; Jinyong YANG ; Xihong JIANG
Chinese Journal of General Surgery 1997;0(04):-
ObjectiveTo evaluate the efficacy and feasibility of extraperitoneal approach (EPA) for the resection of primary retroperitoneal tumors (PRT). MethodsForty six cases undergoing resection of PRT were analyzed retrospectively, of which, 26 cases were through transabdominal approach (TAA group) and 20 through EPA. ResultsThe postoperative complications in EPA group was lower than in TAA group (2/20 vs. 11/26, P
5.Observation of the therapeutic effect of reduced glutathione on liver failure after burn.
Fei-hong LOU ; Bo-yu WU ; Ji-hui YANG ; Zhao-hong CHEN ; Shun-bin WANG ; Shun CHEN
Chinese Journal of Hepatology 2004;12(4):222-222
Adult
;
Aged
;
Burns
;
complications
;
Female
;
Glutathione
;
therapeutic use
;
Humans
;
Liver
;
physiopathology
;
Liver Failure
;
drug therapy
;
physiopathology
;
Male
;
Middle Aged
6.Prognosis of patients with huge hepatocellular carcinoma after R0 resection
Liqun WU ; Bin ZHANG ; Weidong GUO ; Jingyu CAO ; Zusen WANG ; Weiyu HU ; Bing HAN ; Fabo QIU ; Shun ZHANG
Chinese Journal of Hepatobiliary Surgery 2012;18(8):597-600
Objective To study the prognosis of patients with huge hepatocellular carcinoma (HCC) after R0 resection.Methods 517 patients with primary HCC who underwent R0 resection from January 1997 to December 2008 at the Affiliated Hospital of Medical College Qingdao University were analyzed retrospectively.Results The 5-and 10-years overall survivals (OS) in patients with huge HCC (≥10 cm; n=69) and in patients with HCC <10 cm (n=448) were 24%,18% and 49%,30%,respectively.The median OS was 23.0 and 58.0 month (P<0.001,log rank test) ; and the median disease-free survivals (DFS) were 15.3 and 34.8 month (P<0.001),respectively.The recurrence rate within the first year and the extrahepatic recurrence after resection in patients with huge HCC was significantly higher than in patients with HCC <10 cm (44.9% vs.24.3%,P=0.022;32.7% vs.16.0%,P=0.004).Independent poor prognostic factors of OS and DFS for patients with huge HCC after R0 resection were portal hypertension and vascular invasion.Preoperative transcatheter arterial chemoembolization (TACE) was an independent prognostic factor for better DFS.Conclusions Surgical resection for huge HCC is safe and feasible.For huge HCC after resection,portal hypertension and vascular invasion were poor prognostic factors.Preoperative TACE improved DFS after resection.
7.The control study of treatment between dual-antiplatelet aggregation and warfarin in the prevention of thromboembolism in high risk patients of nonvalvular atrial fibrillation GENG
Qingfeng GE ; Meiru LI ; Hongyue LI ; Bin WANG ; Shuzhang AN ; Lijuan CHENG ; Jianti QI ; Yuhui LIU ; Yongli YANG ; Shun CHANG
Chinese Journal of Postgraduates of Medicine 2010;33(1):10-12
Objective To compare the efficiency and safety of aspirin-dipyridamole and warfarin in the prevention of thromboembolism in patients with nonvalvular atrial fibrillation(NVAF)and high risk factors.Methods One hundred and forty NVAF patients with high risk factors were randomly divided into two groups.Warfarin group[78 cases international normalized ratio(INR)2.0-3.0,for the patients older than 75 years,INR ranging from 1.6 to 2.5]and combination group(62 cases received aspirin 160 mg once every day plus dipyridamole 160 mg 3 times every day).The incidence of death,thromboembolism(including stroke and peripheral arteries embolism)and hemorrhage events were observed.Results Followed-up 12-28 months.In warfarin group,3 cases lost,2 cages had stroke,2 cases suffered from serious bleeding events,6 cases had minor bleeding events.In combination group,2 cases lost,6 cases had stroke,and 2 cases suffered from peripheral arteries embolism events,3 cases had minor bleeding events,but no serious bleeding events occurred.The incidence of thromboembolism in warfarin group wag,lower than that in combination group[2.7%(2/75)vs 13.3%(8/60),P<0.05].There was no significant difference of the bleeding rate between the two groups[10.7%(8/75)vs 5.0%(3/60),P>0.05].Conclusions Warfarin anticoagulative therapy is more effective than aspirin and dipyridamole antiplatelet dual therapy for the prevention of thromboembolism events in patients with NVAF and high risk factors.The major bleeding events in warfarin group occurs in patients with INR>3.0,so under intensive monitoring(INR 2.0-3.0),warfarin therapy is effective and safety.
8.Analysis on factors influencing one-year-survival of hepatocellular carcinoma patients after hepatectomy
Liqun WU ; Zusen WANG ; Weiyu HU ; Bing HAN ; Jingyu CAO ; Weidong GUO ; Bin ZHANG ; Fabo QIU ; Shun ZHANG
Chinese Journal of General Surgery 2012;27(2):92-95
Objective To analyze the factors that influence the survival condition during the first year after hepatectomy in patients with hepatocellular carcinoma (HCC). Methods Five hundred twentyeight HCC cases undergoing hepatectomy were included from January 1997 to December 2008.The factors and survival outcomes in these patients were analyzed. Results There were 302 patients dying during a medium follow-up of 35 months and 1-year cumulative survival was 85%.The causes of death during first year were tumor recurrence (78.1%,75/96) and liver dyscompensation ( 19.8%,19/96).By Cox regression analysis,tumor size ≥5 cm (P =0.047 ),vascular invasion ( P =0.018),histologic moderately and poorly differentiation ( P =0.001 ) and pathologically positive margin ( P =0.004 ) were significantly associated with tumor recurrence,and portal hypertension was an independent factor for patients dying from liver dysfunction ( P =0.001 ).Positive tumor margin was the most important factor associated with postoperative death within one year (59.3%,60/96). Conclusions During the first year after HCC resection,tumor recurrence and liver dysfunction are main factors influencing HCC patients' survival,nonR0 resection is the main factor causing tumor recurrence,and portal hypertension is an independent factor for patients dying of liver dyscompensation.
9.Progress study on fixation retainer of splint.
Ai-Guo WANG ; Zhi-Bin WANG ; Hong-Bin JIN ; Fu-Shun GU
China Journal of Orthopaedics and Traumatology 2008;21(12):946-948
Splint fixation is an external fixation system,composed of retainer, splint, paper pad and traction. Pressure under retainer is the power source of splint fixation in treatment of fractures. Now we have a review literature about the progress of type and biomechanics of fixation retainer of splint, to offer the scientific parameters for modern reform of fixation retainer of splint.
Biomechanical Phenomena
;
Humans
;
Splints
;
classification
10.Investigation on the molecular mechanisms of anti-hepatocarcinoma herbs of traditional Chinese medicine by cell cycle microarray.
Guang-Liang WANG ; Cheng-Bin CHEN ; Jian-Ming GAO ; Hong NI ; Tong-Shun WANG ; Li CHEN
China Journal of Chinese Materia Medica 2005;30(1):50-54
OBJECTIVETo design DNA microarray and investigate the molecular anti-tumor mechanism of herbs of traditional Chinese medicine.
METHODcDNA microarrays consisting of 56 probes representing 24 human cell cycle genes were constructed, Four anti-hepatocarcinoma herbs including Radix Linderae, Hebra Artemisiae Annuae, Radix Amebiae, Radix Astragli, were chosen. Effects of herbs on SMMC-7721 cell cycle were observed by flow cytometry assay. Effects of herbs on cell cycle gene expression in SMMC-7721 cells were analyzed by comparing hybridization of Dig-Labeled cDNAs from herb-treated cells and cDNAs from untreated cells.
RESULTExpressions of cell cycle geneswere changed in different degrees after herbs treated. Some genes were down-regulated and some genes were up-regulated. The changes in gene expression agreed with the results of flow cytometry assay.
CONCLUSIONThe results suggest that these herbs may have effects on cell cycle and DNA damage checkpoint genes which may be the mechanism of the herbs, and DNA microarray can be used to investigate the biological function of extracts of traditional Chinese medicine.
Antineoplastic Agents, Phytogenic ; isolation & purification ; pharmacology ; Artemisia ; chemistry ; Astragalus membranaceus ; chemistry ; Carcinoma, Hepatocellular ; metabolism ; pathology ; Cell Line, Tumor ; Cyclin-Dependent Kinase 4 ; Cyclin-Dependent Kinase Inhibitor p16 ; genetics ; metabolism ; Cyclin-Dependent Kinases ; genetics ; metabolism ; Drugs, Chinese Herbal ; isolation & purification ; pharmacology ; Gene Amplification ; Gene Expression Profiling ; Genes, cdc ; drug effects ; Humans ; Lindera ; chemistry ; Lithospermum ; chemistry ; Liver Neoplasms ; metabolism ; pathology ; Oligonucleotide Array Sequence Analysis ; methods ; Plants, Medicinal ; chemistry ; Proliferating Cell Nuclear Antigen ; genetics ; metabolism ; Proto-Oncogene Proteins ; genetics ; metabolism ; cdc25 Phosphatases ; genetics ; metabolism